Cellebrite DI (NASDAQ:CLBT) Price Target Raised to $24.00 at Needham & Company LLC

Cellebrite DI (NASDAQ:CLBT) had its price objective boosted by Needham & Company LLC from $22.00 to $24.00 in a report issued on Thursday morning,Benzinga reports. Needham & Company LLC currently has a buy rating on the stock.

Other equities analysts have also recently issued research reports about the company. Lake Street Capital decreased their price objective on Cellebrite DI from $24.00 to $22.00 and set a “buy” rating for the company in a research note on Friday, August 15th. Wall Street Zen cut Cellebrite DI from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Weiss Ratings raised Cellebrite DI from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, November 7th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Cellebrite DI from $20.00 to $23.00 and gave the company an “overweight” rating in a report on Wednesday, September 24th. Four research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $24.00.

Cellebrite DI Trading Down 4.3%

CLBT traded down $0.83 during mid-day trading on Thursday, hitting $18.45. 2,163,011 shares of the stock were exchanged, compared to its average volume of 1,649,538. The firm’s fifty day moving average is $17.78 and its two-hundred day moving average is $16.71. Cellebrite DI has a 1-year low of $13.10 and a 1-year high of $26.30. The company has a market cap of $4.42 billion, a PE ratio of -24.28, a PEG ratio of 3.16 and a beta of 1.28.

Cellebrite DI (NASDAQ:CLBT) last issued its quarterly earnings results on Wednesday, November 12th. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.05). Cellebrite DI had a positive return on equity of 23.92% and a negative net margin of 34.56%.The business had revenue of $126.03 million for the quarter, compared to analysts’ expectations of $122.98 million. During the same quarter last year, the company earned $0.14 earnings per share. The firm’s revenue for the quarter was up 17.9% on a year-over-year basis. Cellebrite DI has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, research analysts anticipate that Cellebrite DI will post 0.3 earnings per share for the current year.

Hedge Funds Weigh In On Cellebrite DI

Large investors have recently modified their holdings of the business. Financial Management Professionals Inc. acquired a new stake in shares of Cellebrite DI in the third quarter valued at about $28,000. CWM LLC boosted its stake in shares of Cellebrite DI by 85.7% during the 3rd quarter. CWM LLC now owns 1,560 shares of the company’s stock worth $29,000 after acquiring an additional 720 shares in the last quarter. Signaturefd LLC grew its holdings in shares of Cellebrite DI by 68.3% in the 2nd quarter. Signaturefd LLC now owns 2,019 shares of the company’s stock worth $32,000 after acquiring an additional 819 shares during the period. Assetmark Inc. purchased a new position in Cellebrite DI in the 1st quarter valued at approximately $33,000. Finally, PNC Financial Services Group Inc. raised its holdings in Cellebrite DI by 1,998.0% during the second quarter. PNC Financial Services Group Inc. now owns 2,098 shares of the company’s stock worth $34,000 after purchasing an additional 1,998 shares during the last quarter. 45.88% of the stock is owned by hedge funds and other institutional investors.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.